All data are based on the daily closing price as of October 16, 2025
a

ASKA Pharmaceutical Holdings

4886.TSE
13.93 USD
-0.06
-0.43%

Overview

Last close
13.93 usd
Market cap
395.18M usd
52 week high
17.48 usd
52 week low
11.96 usd
Target price
16.52 usd

Valuation

P/E
11.7422
Forward P/E
N/A
Price/Sales
0.8931
Price/Book Value
0.9531
Enterprise Value
455.43M usd
EV/Revenue
1.0743
EV/EBITDA
8.1162

Key financials

Revenue TTM
443.54M usd
Gross Profit TTM
210.14M usd
EBITDA TTM
47.57M usd
Earnings per Share
1.19 usd
Dividend
0.36 usd
Total assets
714.50M usd
Net debt
51.04M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. It operates through three segments: The Pharmaceutical Business, The Animal Health Business, and The Overseas Business. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. In addition, the company manufactures and sells ethical pharmaceutical overseas. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top